Related Experiment Videos
Is there any relationship between hepatitis C virus and vitiligo?
Nihat Akbayir1, Gonca Gökdemir, Tülin Mansur
1Department of Gastroenterology, SiSli Etfal Education and Research Hospital, Turkey. akbayirn@hotmail.com
Journal of Clinical Gastroenterology
|September 15, 2004
Summary
Hepatitis C virus (HCV) seropositivity in vitiligo patients was investigated. The study found no significant difference in HCV prevalence between vitiligo patients and healthy controls, suggesting HCV may not drive vitiligo development.
Area of Science:
- Immunology
- Hepatology
- Dermatology
Background:
- Hepatitis C virus (HCV) is linked to autoimmune diseases.
- The connection between HCV and vitiligo, an autoimmune-related skin condition, remains unclear.
Purpose of the Study:
- To investigate Hepatitis C virus (HCV) seropositivity in vitiligo patients.
- To compare HCV prevalence in vitiligo patients with a healthy control group.
Main Methods:
- Included 102 vitiligo patients and 670 healthy controls.
- Used third-generation enzyme immunoassay for anti-HCV antibodies.
- Confirmed positive cases with HCV-RNA determination via RT-PCR.
Main Results:
- Detected anti-HCV antibodies in only one vitiligo patient (0.98% incidence).
- No statistically significant difference in HCV seropositivity compared to healthy blood donors (0.6% prevalence).
Conclusions:
- Seroprevalence of HCV in vitiligo patients is similar to the general population in Turkey.
- HCV infection is unlikely to be a primary factor in vitiligo pathogenesis, despite co-occurrence reports.